J Pediatr Infect Dis 2020; 15(01): 031-038
DOI: 10.1055/s-0039-1696977
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Clinical Characteristics, Acute Complications, and Neurologic Outcomes of Salmonella Meningitis in Saudi Infants and Children

Sarah Alsubaie
1   Pediatric Infectious Diseases Unit, Department of Pediatrics, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia
,
Abdulkarim Alrabiaah
1   Pediatric Infectious Diseases Unit, Department of Pediatrics, Faculty of Medicine, King Saud University, Riyadh, Saudi Arabia
› Author Affiliations
Further Information

Publication History

01 March 2019

29 July 2019

Publication Date:
16 September 2019 (online)

Abstract

Objective This study aimed to clarify the clinical presentations, acute complications, and long-term sequelae of Salmonella meningitis in Saudi infants and children.

Methods This retrospective study, conducted from 1999 to 2016, evaluated the neurological complications and long-term outcomes of children 14 years of age and younger diagnosed with Salmonella meningitis at King Khalid University Hospital. All affected children had 3 years of follow-up to assess neurologic complications and mortality.

Results Invasive Salmonella infection occurred in 141 patients. Of those, 14 (10%) had meningitis. The median age of onset of infection was 4.7 months. The most frequent symptoms at presentation included fever (100%), seizures (71%), diarrhea, and vomiting (43%). Nontyphoidal Salmonella species were isolated in all (but one) cerebrospinal fluid samples. Relapse occurred in four patients owing to inadequate antibiotic duration, although the organisms were susceptible to ceftriaxone. The majority of patients (86%) developed acute neurologic complications, including subdural empyema and multiple cerebral infarcts (57%), hydrocephalus (36%), ventriculitis (29%), and cerebral venous sinus thrombosis (21%). Four patients (28.5%) died due to Salmonella meningitis complications. Four patients survived with full recovery. Six patients (60%) had long-term neurologic complications. Hydrocephalus, cerebral palsy, developmental delay, and epilepsy occurred in five, four, three, and three patients, respectively.

ConclusionSalmonella meningitis results in significant mortality and adverse neurodevelopmental outcomes. The probability of relapse after an apparent recovery should be considered. Consensus on antibiotic treatment for Salmonella meningitis is needed.

 
  • References

  • 1 Statistical yearbook 1438H. Available from: https://www.moh.gov.sa/en/Ministry/Statistics/book/Pages/default.aspx . Accessed 20 December 2018
  • 2 American Academy of Pediatrics. Salmonella infections. In: Kimberlin D, Brady M, Jakson M, Long S. , eds. Red Book: 2018 Report of the Committee on Infectious Diseases. 31st edition. Itasca, IL: American Academy of Pediatrics; 2018: 711-718
  • 3 Tapia MD, Tennant SM, Bornstein K. , et al. Invasive nontyphoidal salmonella infections among children in Mali, 2002–2014: microbiological and epidemiologic features guide vaccine development. Clin Infect Dis 2015; 61 (Suppl. 04) S332-S338
  • 4 Rudolph CD, Rudolph AM, Hostetter MK, Lister G, Siegel NJ. , eds. Rudolph's Pediatrics. 21st edition. New York: McGraw Hill Medical; 2003
  • 5 Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis 2001; 32 (02) 263-269
  • 6 Marks F, von Kalckreuth V, Aaby P. , et al. Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study. Lancet Glob Health 2017; 5 (03) e310-e323
  • 7 Price EH, de Louvois J, Workman MR. Antibiotics for Salmonella meningitis in children. J Antimicrob Chemother 2000; 46 (05) 653-655
  • 8 Lee WS, Puthucheary SD, Omar A. Salmonella meningitis and its complications in infants. J Paediatr Child Health 1999; 35 (04) 379-382
  • 9 Pabst HF, Kreth HW. Ontogeny of the immune response as a basis of childhood disease. J Pediatr 1980; 97 (04) 519-534
  • 10 van Sorge NM, Zialcita PA, Browne SH, Quach D, Guiney DG, Doran KS. Penetration and activation of brain endothelium by Salmonella enterica serovar Typhimurium. J Infect Dis 2011; 203 (03) 401-405
  • 11 van den Berg JM, van Koppen E, Ahlin A. , et al. Chronic granulomatous disease: the European experience. PLoS One 2009; 4 (04) e5234
  • 12 MacLennan C, Fieschi C, Lammas DA. , et al. Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J Infect Dis 2004; 190 (10) 1755-1757
  • 13 Denis F, Badiane S, Chiron JP, Sow A, Mar ID. Salmonella meningitis in infants. Lancet 1977; 1 (8017): 910
  • 14 Molyneux EM, Walsh AL, Malenga G, Rogerson S, Molyneux ME. Salmonella meningitis in children in Blantyre, Malawi, 1996-1999. Ann Trop Paediatr 2000; 20 (01) 41-44
  • 15 Kavaliotis J, Tsiaousi A, Papavasiliou D, Kansouzidou A. Non-typhoid Salmonella meningitis. Scand J Infect Dis 1994; 26 (04) 403-405
  • 16 McIntyre P, Jepson R, Leeder S, Irwig L. The outcome of childhood Haemophilus influenzae meningitis. A population based study. Med J Aust 1993; 159 (11-12): 766-772
  • 17 Vázquez-López ME, Pego R, Somoza C, García-Plata C, Rodríguez-De la Riva P, Morales-Redondo R. Meningitis due to Salmonella in the neonatal period [Article in Spanish]. Rev Neurol 1998; 27 (160) 986-987
  • 18 Visudhiphan P, Chiemchanya S, Visutibhan A. Salmonella meningitis in Thai infants: clinical case reports. Trans R Soc Trop Med Hyg 1998; 92 (02) 181-184
  • 19 Huang LT, Ko SF, Lui CC. Salmonella meningitis: clinical experience of third-generation cephalosporins. Acta Paediatr 1997; 86 (10) 1056-1058
  • 20 Lecour H, Seara A, Cordeiro J, Miranda M. Treatment of childhood bacterial meningitis. Infection 1989; 17 (05) 343-346
  • 21 Koç E, Turkyilmaz C, Atalay Y, Sen E. Imipenem for treatment of relapsing Salmonella meningitis in a newborn infant. Acta Paediatr Jpn 1997; 39 (05) 624-625
  • 22 Owusu-Ofori A, Scheld WM. Treatment of Salmonella meningitis: two case reports and a review of the literature. Int J Infect Dis 2003; 7 (01) 53-60
  • 23 Bryan JP, Scheld WM. Therapy of experimental meningitis due to Salmonella enteritidis. Antimicrob Agents Chemother 1992; 36 (05) 949-954
  • 24 Cuffini AM, Tullio V, Allocco A, Giachino F, Fazari S, Carlone NA. The entry of meropenem into human macrophages and its immunomodulating activity. J Antimicrob Chemother 1993; 32 (05) 695-703
  • 25 Mongelluzzo J, Mohamad Z, Ten Have TR, Shah SS. Corticosteroids and mortality in children with bacterial meningitis. JAMA 2008; 299 (17) 2048-2055
  • 26 Chiu CH, Ou JT. Persistence of Salmonella species in cerebrospinal fluid of patients with meningitis following ceftriaxone therapy. Clin Infect Dis 1999; 28 (05) 1174-1175
  • 27 Hardy C, Bansal A, Lowes JA, George CF. Salmonella meningitis following treatment of enteritis with neomycin. Postgrad Med J 1984; 60 (702) 284-286
  • 28 Huang LT. Salmonella meningitis complicated by brain infarctions. Clin Infect Dis 1996; 22 (01) 194-195
  • 29 Molyneux EM, Mankhambo LA, Phiri A. , et al. The outcome of non-typhoidal salmonella meningitis in Malawian children, 1997-2006. Ann Trop Paediatr 2009; 29 (01) 13-22
  • 30 Weatherhead J, Revell P, Munoz F. Salmonella meningitis in children at Texas Children's Hospital. J Pediatr Infect Dis 2012; 7: 9-14
  • 31 Messer RD, Warnock TH, Heazlewood RJ, Hanna JN. Salmonella meningitis in children in far north Queensland. J Paediatr Child Health 1997; 33 (06) 535-538
  • 32 Sirinavin S, Chiemchanya S, Vorachit M. Systemic nontyphoidal Salmonella infection in normal infants in Thailand. Pediatr Infect Dis J 2001; 20 (06) 581-587
  • 33 Grimwood K, Anderson P, Anderson V, Tan L, Nolan T. Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child 2000; 83 (02) 111-116
  • 34 de Louvois J, Halket S, Harvey D. Neonatal meningitis in England and Wales: sequelae at 5 years of age. Eur J Pediatr 2005; 164 (12) 730-734